HomeCN2 • FRA
add
Catalyst Pharmaceuticals Inc
Previous close
€21.74
Day range
€21.84 - €21.84
Year range
€12.21 - €22.80
Market cap
2.79B USD
Avg Volume
76.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 128.70M | 25.33% |
Operating expense | 55.22M | 31.34% |
Net income | 43.88M | 242.65% |
Net profit margin | 34.10 | 213.82% |
Earnings per share | 0.57 | 296.55% |
EBITDA | 60.36M | 310.90% |
Effective tax rate | 23.29% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 442.33M | 265.65% |
Total assets | 772.01M | 86.83% |
Total liabilities | 111.07M | 71.77% |
Total equity | 660.94M | — |
Shares outstanding | 119.27M | — |
Price to book | 3.92 | — |
Return on assets | 17.22% | — |
Return on capital | 19.94% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 43.88M | 242.65% |
Cash from operations | 72.87M | 61.48% |
Cash from investing | -259.00K | 99.72% |
Cash from financing | -5.97M | 41.01% |
Net change in cash | 66.64M | 215.26% |
Free cash flow | 60.57M | 164.47% |
About
Founded
2002
Headquarters
Website
Employees
167
